Leucocyte chemotaxis is an important aspect of the immunological defence mechanism. Following bacterial invasion or immunological reactions, circulating leucocytes adhere to capillary walls and are stimulated to move between the endothelial cells towards the nidus of inflammation. Such directional locomotion is termed chemotaxis and occurs along a concentration gradient of protein and polypeptide substances, termed cytotaxins or chemotactic factors, released by invading micro-organisms, inflammatory leucocytes, tissue debris or antigen-antibody reactions. Leucocytes move from a small to a greater'concentration of cytotaxin. Hence an efficient inflammatory response is dependent both on the adequate generation of chemotactic factors and on normal leucocyte responsiveness to chemotactic stimulation (Wilkinson, 1974) .
Many proteins have been found to stimulate chemotactic activity by either direct or indirect actions on circulating leucocytes. Direct acting cytotaxins may be endogenous, such as activated complement, or exogenous, such as bacterial breakdown products. Such direct-acting cytotaxins are usually considered to stimulate only one cell type, either polymorphonuclear neutrophils, eosinophils or circulating macrophages. Lymphocytes do not respond to known chemotactic stimulants. Indirectacting stimulators of chemotaxis, termed cytotaxigens, do not act directly on the leucocyte but rather activate normal constituents of plasma to become cytotaxic. Activation of complement by antigen-antibody reactions or zymosan, a yeast wall extract, are examples of indirect cytotaxin generation (Keller, Hess and Cottier, 1975) .
Assessment of leucocyte chemotaxis in vitro is usually performed by the method described by Boyden (1962) with appropriate modifications. Using this technique, it has been possible to identify patients with defective leucocyte chemotaxis as a result of genetic or infectious causes. Such individuals present with recurrent pyogenic infections associated with an impaired inflammatory response (Miller, Oski and Harris, 1971) . Because anaesthetic drugs can inhibit many cellular processes (Nunn, 1972) , including some aspects of the immune response (Duncan and Cullen, 1976) , we felt it was reasonable to evaluate the effect of common anaesthetic agents on human neutrophil chemotaxis as a possible aetiological factor in perioperative infections. We found that normal human leucocytes, incubated in vitro with clinical concentrations of halothane and thiopentone, do not demonstrate any impairment of chemotaxis.
METHODS AND MATERIALS
Chemotaxis was assessed in a modified Boyden chamber by the radioassay technique of Gallin, Clark and Kimball (1973) . Peripheral leucocytes were placed in the upper compartment of a twocompartment chamber, separated by two micropore filters from a known cytotaxin in the lower compartment. The filter pores were small enough to prevent simple diffusion of cells, but large enough to permit movement of activated cells in response to a chemotactic stimulus. After a short incubation the proportion of cells migrating through the filters could be quantitated by radioisotope labelling. The upper filter contained residual red blood cells and unstimulated leucoctyes, while the lower filter contained neutrophils which had moved in response to stimulation.
Venous blood was drawn from healthy human volunteers into a heparin-rinsed syringe, mixed with Dextran T-250 (Sigma Chemical Co., St Louis, Missouri) and leucocyte-rich plasma obtained after 25 min of sedimentation. Residual erythrocytes were lysed by a 30-s exposure to hypotonic saline. The leucocytes were washed, counted electronically and resuspended in modified Hank's balanced salt solution (Grand Island Biological Co., Grand Island, N.Y.) (Mhs) at a concentration of 25 x 10 6 leucocytes/ml. One microcurie of Na 2 51 CrO 4 per 10 6 leucocytes was added and the mixture was incubated with agitation for 60 min at 37 °C.
Following labelling, the leucocytes were washed twice and resuspended in Mhs. Quantitative and differential cell counts were performed in a haemocytometer and the final cell concentration was adjusted to 2.3 x 10 6 granulocytes/ml. The cell suspension was divided into two aliquots and the granulocytes were resuspended in RPMI-1640 (Grand Island Biological Co., Grand Island, N.Y.) supplemented with penicillin, streptomycin and 1% bovine serum albumin. One aliquot of granulocytes was previously equilibrated for 1 h with air at 37 °C, while the other was previously equilibrated for 1 h at 37 °C in the anaesthetic under study. The concentration of halothane present in the media was confirmed by gas chromatography.
Chemotactic factor was generated from 0.4 ml of autologous human serum by a 1-h incubation with zymosan 0.2 mg (Sigma Chemical Company, St Louis, Missouri) prepared in 4.0 ml of gelatin veronal buffer (GVB) at pH 7.40. Following activation, the mixture was heat-inactivated at 56 °C for 30 min, leaving the heat-stable activated fifth component of complement (C 5^) to act as cytotaxin. The chemotactic factor was split into two equal portions, each portion diluted with an equal volume of GVB, and equilibrated with either air or the anaesthetic under study. Thus the lower chamber also contained anaesthetic, although the chemotactic factor was generated before exposure to any drugs.
Two directly apposed 3-fj.m micropore filters (Sartorius Membranfilter, Gottingen, West Germany) were placed in modified Boyden chambers (Ahlco Scientific, Granby, Connecticut). The chemotactic factor was placed in the lower compartment of the chemotactic chamber, followed immediately by 0.5 ml of labelled cell suspension in the upper compartment. To assess unstimulated or random movement of granulocytes through the membranes, control chambers were prepared with labelled cells in the upper compartment but GVB without chemotactic factor in the lower. Ten chambers were used for each experiment, five as controls and five treated with anaesthetics. All chambers were incubated for 3 h at 37 °C, 100% humidity, in 5% carbon dioxide in air except in those studies with halothane in which the test chambers were placed in an identical incubator with a calibrated vaporizer on the gas inflow line. Halothane concentrations were monitored with a Beckman LBII infra-red analyser. Chemotaxis was assessed in the presence of halothane 0.5%, 1.0% and 2.0% and thiopentone 5.7 x 10~5 mol/litre (equivalent to peak blood concentration attained after induction doses of 4 mg/kg).
Following incubation, the fluid was aspirated from both compartments and the filters removed. The lower filter was rinsed by dipping in saline and then placed in a scintillation vial for counting. Chemotactic activity was expressed as the percentage of radiolabelled granulocytes that migrated into the lower filter and was calculated as follows: Per cent chemotaxis = xlOO CPM t(otal where CPM = counts per minute stimulated = filters from chambers with chemotactic factor unstimulated = filters from chambers with GVB only total = total granulocyte radioactivity added to the chambers.
The viability of granulocytes in the presence of anaesthetic was determined by counting total radioactivity in an aliquot of cells before and after 3 h of incubation. The pH of the chambers was monitored to assure no change with drug treatment.
In a separate study, the total haemolytic complement activity (CH 50 ) of normal serum was determined before and after 4 h of exposure to halothane 2% at 20 and 37 °C. Complement activity was measured by measuring its ability to support haemolysis of antibody-coated sheep red blood cells (Nowatany, 1969) .
All data were analysed by Student's t test for paired data with the level of significance set at RESULTS Anaesthetic treatment of normal human leucocytes in vitro did not affect their response to a chemotactic stimulus. In fact the higher concentrations of halothane (1.0 and 2.0%) were associated with a tendency to increased migration of granulocytes (table I) although this was not statistically significant. Thiopentone 5.7 x 10~5 mol/litre also did not affect neutrophil chemotaxis (table II) . Furthermore, neither drug significantly altered unstimulated motility, that is, the number of cells migrating to the lower filter in the absence of a chemotactic stimulus.
There was no change in viability of leucocytes over a 3-h incubation period, as measured by their ability to retain the chromium label. There was no alteration in culture pH secondary to anaesthetic treatment. Finally, halothane treatment of normal serum did not affect the functional capacity of the complement system as assessed by the total haemolytic component (table III) .
DISCUSSION
Leucocyte chemotaxis occurs by complex biochemical and physical mechanisms which have begun to be clarified only recently. Currently it is believed that chemotactic factor stimulates the cell to extend a pseudopod in the area in which the factor attaches to the cell receptor. This extension of the pseudopod involves the contractile machinery of the cell, particularly the fine microfilament network (Spooner, Yamadaand Wessells, 1971) . Actomyosin-like proteins may also be involved in a contractile process similar to that of skeletal muscle (Senda et al., 1969) . Energy is provided by a burst of anaerobic glycolysis and stimulation of the hexose-monophosphate shunt, with little dependence on oxidative metabolism (Ward, 1966) . By amoeboid motion, the cell then moves up the concentration gradient to the origin of the chemotactic stimulant. It has been reported that chemotaxis is reduced significantly during general anaesthesia in vivo (Stanley et al., 1976) . The inhibition is greatest immediately following induction of anaesthesia and returns towards normal as the operation progresses. This inhibition of chemotaxis associated with general anaesthesia could be a result of either a direct action of the anaesthetics on the chemotactic process, or, indirectly, the influence of other factors associated with anaesthesia and surgery.
If inhibition of chemotaxis is a result of a direct action of anaesthetic agents, it could occur through a failure to generate normal chemotactic factors, interference with the reaction of cytotaxins with the cell receptor or reduction in mobility of the stimulated cell. We cannot exclude the first possibility as our chemotactic factor was generated in the absence of an anaesthetic, but the failure to demonstrate altered complement haemolytic activity in the presence of halothane in vitro would suggest that such a mechanism is improbable. Our findings of normal chemotaxis in the presence of halothane and thiopentone in vitro exclude the latter two mechanisms, that is, interference with cytotaxin-leucocyte interaction or neutrophil mobility. Moudgil and colleagues (1977) reported contrary findings of inhibition of human leucocyte locomotion in vitro by local, i.v. and volatile anaesthetics. Although the principles of their assay were similar to ours, subtle differences in techniques may explain the discrepancy in results. Most significantly, we used albumin in our cultures to sustain cell viability, buffer pH changes and provide a more physiological milieu of protein binding of the drugs during incubation. Thus we may have been using lower effective drug concentrations than in Moudgil's study in which protein moieties were not employed. Such difficulties inherent to in vitro assays suggests that such data can be extrapolated to patients only with great caution.
Nevertheless, that neutrophil function is relatively free from interference by anaesthetics is supported indirectly by several other reports. Leucocyte phagocytosis, an event closely related, biochemically and physically, to neutrophil chemotaxis, is affected minimally during anaesthesia in vivo (Cullen, 1975) and unaffected by halothane or nitrous oxide in vitro (Cullen, 1974) . Halothane anaesthesia does not impair the ability of a mouse to mount a normal inflammatory response to localized sepsis (Duncan, Cullen and Persall, 1976) , suggesting that leucocyte chemotaxis is intact in vivo. Finally, general anaesthesia and surgery do not affect leucocyte accumulation as assessed by Rebuck's skin window technique (Brayton et al., 1970) .
It is more likely that the inhibition of chemotaxis observed in patients by Stanley and colleagues (1976) is the result of factors other than the anaesthetic agent. These might include alterations in temperature, blood pH, systemic arterial oxygen tension or neurohumoral stress responses associated with anaesthesia and surgery. Neutrophil chemotaxis can be altered by a multiplicity of physiological changes and drugs. It can be inhibited by colchicine (Borel and Feurer, 1975) , sodium salicylates (Borel and Feurer, 1975) , caffeine (Phelps and Stanslaw, 1969) , catecholamines (Hill et al., 1975) , drugs which increase cellular cyclic AMP (Hill et al., 1975) and small changes in pH (Phelps and Stanslaw, 1969) . On the other hand, it can be facilitated by some prostaglandins (Diaz-Perez, Goldyne and Winkelmann, 1976) and by drugs which increase cellular cyclic GMP (Sandier, Gallin and Vaughan, 1975) . Any one of several factors could be operative in depressing chemotaxis in the surgical patient.
Because chemotaxis is a contractile process involving cellular microtubules and microfilaments, one might expect that anaesthetic agents would exert an inhibitory effect. Anaesthetic drugs have been reported to impair the motility of various unicellular organisms (Bruce and Christiansen, 1965; Sharp, Nunn and Dixon, 1969; Wicklund and Allison, 1972) and mouse lymphocytes (Nunn, Sharp and Kimball, 1970) , a phenomenon thought to be secondary to reversible disruption of cellular microtubules and microfilaments (Allison and Nunn, 1968) . Our results suggest that human neutrophils are resistant to such effects and that anaesthetic derangement of microtubules and microfilaments is probably species-or cell-specific. Other phenomena dependent on intact microtubular systems are also unaffected by anaesthetic agents (Fink and Kennedy, 1972) .
In summary, although an inhibition of neutrophil chemotaxis has been observed in anaesthetized patients (Stanley et al., 1976) we have been unable to demonstrate any direct inhibitory effect from halothane or thiopentone in vitro at concentrations used clinically. The inhibitory effects of other perioperative factors, and the clinical significance of this inhibition, have yet to be determined.
QUIMIOTAXIS NEUTROFILA Y ANESTESIA

SUMARIO
Empleando una modification de la tecnica de Boyden, se evaluo la capacidad de los neutrofilos humanos normales para desplazarse en respuesta a la estimulacion quimiotactica durante la exposition in vitro al halotano y tiopental. No pudo demostrarse ninguna anomalia en la quimiotaxis neutrofila con ninguno de los agentes anestesicos a concentraciones usadas clinicamente. Tampoco afectaron los anestesicos al complemento serico, que fue empleado como estimulante quimiotactico. Se concluye que al helotano y el tiopental ejercen escaso efecto directo sobre la actividad quimiotactica de los neutrofilos en el hombre.
CHIMIOTAXIE DES LEUCOCYTES NEUTROPHILES ET ANESTHESIE
RESUME
A l'aide d'une technique de Boyden modifiee, on a evalue la faculte que possedent les leucocytes neutrophiles de l'homme normal a se deplacer en reponse a une stimulation chimiotactique, au cours d'une exposition in vitro a l'halothane et au thiopentone. On n'a pu prouver aucune anomalie dans la chimiotaxie des leucocytes neutrophiles avec l'un ou l'autre de ces agents aux concentrations utilisees cliniquement. Les agents anesthesiques n'ont pas non plus affecte le complement de serum, qui a ete utilise comme stimulant chimiotactique. On en conclut que l'halothane et le thiopentone n'ont que peu d'effets directs sur l'activite chimiotactique des leucocytes neutrophiles chez l'homme. 
NEUTROPHILE CHEMOTAXIS UND ANASTHESIE
ZUSAMMENFASSUNG
